CHRS (Coherus BioSciences) Wutah bathi resik saben saham ing taun iki

CHRS (Coherus Biosciences) - tandha merek perusahaan

Coherus Biosciences (CHRS) is currently shifting its strategic direction, pivoting from biosimilars toward the development of its own immuno-oncology pipeline and cost optimization. A key advantage is its monopoly in treating rare carcinomas, despite pricing battles in other segments. However, logistical disruptions and sanctions are limiting expansion. The annual change in earnings per share reflects the pace of the business turnaround, where 43.10 expresses the current value of the metric.

Wutah bathi saben saham ing taun lumaku: Coherus (CHRS) kanggo 04.07.2022 - 17.11.2026

Rincian metrik keuangan lan pasar coherus.com (CHRS)

Ringkesan analisis perusahaan:CHRS Coherus Biosciences
Produk mawa merek Coherus Biosciences

Coherus Biosciences (CHRS) specializes in developing affordable biosimilars and introducing the innovative drug Loqtorzi into the oncology segment. By analyzing the EPS YoY percentage shift, an investor assesses the rate of change in net income per share relative to the previous year, which allows for determining the effectiveness of the business model's adaptation to the cost of borrowed capital and the company's overall profitability resilience.

Pesaing wigati

Wutah bathi saben saham ing taun iki INCY|Wutah bathi saben saham ing taun lumaku Hutchison MediPharma|Wutah bathi resik saben saham ing taun iki nuvationbio.com (NUVB)|Wutah bathi saben saham ing taun lumaku Day One Biopharmaceuticals Inc (DAWN)|MNPR - Kacepetan wutah bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku Inhibrx Biosciences Inc INBX|I-Mab - Wutah bathi saben saham ing taun lumaku|FENC - Wutah bathi saben saham ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku herontx.com|NVCT: Wutah bathi ing taun lumaku|Owah-owahan bathi resik saben saham ing taun lumaku Corbus Pharma CRBP|Wutah bathi resik saben saham ing taun iki CRDF|Kacepetan wutah bathi saben saham ing taun lumaku BeyondSpring Inc. BYSI|Wutah bathi resik saben saham ing taun iki BCAB (BioAtla Inc)|LIXT (Lixte Biotechnology Holdings, Inc.) - Tambahing bathi saben saham ing taun lumaku|Citius Pharmaceuticals, Inc. - Wutah bathi resik saben saham ing taun iki|Wutah bathi resik saben siji saham kanggo taun lumaku CLRB (Cellectar Biosciences, Inc.)|BioLineRx Corp - Wutah bathi ing taun lumaku|Tambahing bathi saben saham ing taun lumaku CANF (Can-Fite BioPharma, Ltd.)|APRE: Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Kazia (KZIA)|Wutah bathi saben saham ing taun lumaku silexion.com|NCNA: Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku CMRX|Wutah bathi ing taun lumaku Cyclacel, Inc. (CYCC)|Wutah bathi saben saham ing taun lumaku G1 Therapeutics Inc. GTHX|KRON (Kronos Bio) - Dinamika bathi saben saham ing taun lumaku|KTRA: Wutah bathi resik saben saham ing taun iki|Kacepetan wutah bathi saben saham ing taun lumaku Oncternal Therapeutics Inc|Portage Biotech (PRTG) - Wutah bathi saben saham ing taun lumaku